arsenic trisulfide has been researched along with Cancer of Stomach in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Deng, L; Fan, Q; Hu, B; Hu, J; Lu, C | 1 |
| Chen, S; Kang, T; Tan, Z; Zhang, X; Zhu, C | 1 |
| Chen, S; Ge, M; Kang, T; Liu, H; Tan, Z; Wang, R; Zhang, X; Zhu, C | 1 |
| Chen, S; Kang, T; Tan, Z; Zhang, L; Zhang, X | 1 |
| Chen, S; Ding, W; Kim, S; Tian, W; Tong, Y; Zhang, L | 1 |
| Chen, S; Ding, W; Kim, S; Pan, M; Tong, Y; Zhang, L; Zhang, X | 1 |
| Chen, S; Pan, M; Tong, Y; Zhang, L; Zhang, X | 1 |
7 other study(ies) available for arsenic trisulfide and Cancer of Stomach
| Article | Year |
|---|---|
Arsenic sulfide inhibits the progression of gastric cancer through regulating the circRNA_ASAP2/Wnt/β-catenin pathway.
Topics: Apoptosis; Arsenicals; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; GTPase-Activating Proteins; Humans; Ki-67 Antigen; RNA, Circular; Stomach Neoplasms; Sulfides; Wnt Signaling Pathway | 2022 |
Arsenic sulfide induces miR-4665-3p to inhibit gastric cancer cell invasion and migration.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasm Proteins; Stomach Neoplasms; Sulfides; Up-Regulation | 2019 |
Arsenic sulfide induces RAG1-dependent DNA damage for cell killing by inhibiting NFATc3 in gastric cancer cells.
Topics: Animals; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Mice; NFATC Transcription Factors; Prognosis; Reactive Oxygen Species; Sequence Analysis, RNA; Stomach Neoplasms; Sulfides; Xenograft Model Antitumor Assays | 2019 |
Arsenic sulfide amplifies JQ1 toxicity via mitochondrial pathway in gastric and colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Azepines; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Membrane Potentials; Mitochondria; Stomach Neoplasms; Sulfides; Triazoles; Tumor Cells, Cultured | 2018 |
Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenicals; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; Mice, Nude; Stomach Neoplasms; Structure-Activity Relationship; Sulfides; Tumor Cells, Cultured | 2015 |
Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Arsenicals; beta Catenin; Cadherins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Signal Transduction; Sp1 Transcription Factor; Stomach Neoplasms; Sulfides; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |
Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenicals; Azepines; Camptothecin; Celecoxib; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; p38 Mitogen-Activated Protein Kinases; Stomach Neoplasms; Sulfides; Triazoles; Tumor Suppressor Protein p53 | 2015 |